Learn more about Joy and her recap of 2022 at GenomSys and her outlook for 2023 for herself and the company through the following quick questions:
Hello and happy New Year Joy. What was your most outstanding achievement at GenomSys in 2022?
In my opinion, our most outstanding achievement was demonstrating our high flexibility in implementing new pipelines adjusted to the new individual need. In 2021 we struggled to have only one single pipeline (WES Germline pipeline for GenomSys Variant Analyzer), but in 2022 we implemented TRIO WES pipeline, blood type pipeline, WGS germline pipeline, improved CNVs analysis and twisted somatic WES pipeline. All native in the MPEG-G format including all the new genomic standard benefits. I think our productivity from the team is a great achievement for the entire company and the perfect basis to move forward in 2023!
What was the most important thing you learned in 2022?
In 2022 I had the opportunity to learn more about Snakemake (our pipeline orchestrator). With the Bioinformatician team, I implemented a modularized Snakemake Pipeline where each step of the analysis is a puzzle piece. We can now use it on its own or create other pipelines with this orchestrator. I also started to use more complex objects in Snakemake to broaden my horizon in developing bioinformatic pipelines.
What are your expectations for you and/or GenomSys for 2023?
In 2023 I expect to implement our somatic WES pipeline and TRIO WES germline certification. Then I expect to reach a broader market with our Pipeline Toolkit! All in order to help those who work in the genomic field to analyze DNA without worrying about data processing and ultimately help patients.
If you have any further questions for Joy or about GenomSys, please feel free to contact us.
